Aquestive Therapeutics Stock Discussion

$Aquestive Therapeutics (AQST.US)$ bring it on

$Aquestive Therapeutics (AQST.US)$
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
Thursday, 19th December at 8:00 am
WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery te...

$Aquestive Therapeutics (AQST.US)$ Reuters
1 min ago
Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms Nda Submission Guidance for Anaphylm™ (Epinephrine) Sublingual Film

$Aquestive Therapeutics (AQST.US)$
Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film
Aquestive Therapeutics (NASDAQ: AQST) announced positive topline results from its Oral Allergy Syndrome (OAS) challenge study for Anaphylm™ sublingual film. The study met both primary and secondary endpoints, demonstrating rapid symptom resolution beginning two minutes after administration. The median time for...

$Aquestive Therapeutics (AQST.US)$ Reuters· 1 min ago
Aquestive Therapeutics Inc - Oas Challenge Study Meets Primary and Secondary Endpoints

$Aquestive Therapeutics (AQST.US)$ the monopoly has been going for long enough.

$Aquestive Therapeutics (AQST.US)$ ownership is 5.99% they see the value in the company as much as we do. FDA approval, production and distribution will significantly increase value. Plus, eliminate PFIZER monopoly in market l.